Takeda Bio Development Center Limited – Asian Scientist Magazine

takeda bio development center limited

Takeda Initiates Phase 3 Trial For Lung Cancer Drug

Takeda Pharma announced yesterday the initiation of a Phase 3 clinical trial involving 400 patients across Japan, Hong Kong, South Korea, and Taiwan.

Pharma

Takeda’s Orteronel Enters Phase III Clinical Trials For Prostate Cancer

Takeda has initiated enrollment of patients in Japan for the two ongoing global Phase III clinical trials for its anti-prostate cancer investigational agent, orteronel (TAK-700).

EDITOR’S PICK

The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.
Making Precision Medicine Equitable

Researchers and policymakers in Asia are trying to make medical research more inclusive to better serve the region’s diverse communities.
Heart Research Has A Gender Bias

The underrepresentation of women in heart research and treatment has perpetuated the widespread misconception that cardiovascular diseases are more common in men. Some women researchers in Asia have come forward to challenge that.

Takeda Initiates Phase 3 Trial For Lung Cancer Drug

Takeda’s Orteronel Enters Phase III Clinical Trials For Prostate Cancer

EDITOR’S PICK

The Equalizers

Making Precision Medicine Equitable

Heart Research Has A Gender Bias